Clinical Trial Update: A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating GLPG3667 in adults with active systemic lupus erythematosus is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• GLPG3667

Snippet

Sponsor: Galapagos NV | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: ACTIVE_NOT_RECRUITING